Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Mohammad Muhsin Chisti, MD

Advertisement

Articles by Mohammad Muhsin Chisti, MD

7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features

ByNidhi Navaratna,Mariam Aoun,Nitya Batra,Mohammad Muhsin Chisti, MD
July 11th 2025

How We Treat Tumor Lysis Syndrome

ByAlaa Muslimani, MD,Mohammad Muhsin Chisti, MD,Laura Nadeau, MD,Dana Zakalik, MD,Hamed Daw, MD,James Huang, MD,Ishmael Jaiyesimi, DO
April 15th 2011

When tumor cells are rapidly broken down and their contents released into the extracellular space, the released ions and compounds can cause metabolic disturbances too great to be neutralized by the body's normal mechanisms.

Advertisement

Latest Updated Articles

  • How We Treat Tumor Lysis Syndrome
    How We Treat Tumor Lysis Syndrome

    April 15th 2011



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Approves SC Amivantamab for Recurrent/Metastatic HNSCC

2

Setting Up an HDR Brachytherapy Program Amid a National Decline

3

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

4

Biomarker Sequencing, PD-L1 Status, and FLOT Dosing in Gastroesophageal Cancer

5

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us